Abeona Therapeutics's market cap is currently $228.66M. The company's EPS TTM is $-2.697; its P/E ratio is ―; Abeona Therapeutics is scheduled to report earnings on March 24, 2025, and the estimated EPS forecast is $-0.35. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 3.50M	$ 1.41M	$ 3.00M	$ 10.00M	$ 0.00
Gross Profit	$ 1.90M	$ 964.00K	$ -1.46M	$ -20.14M	$ -8.68M
Operating Income	$ -47.13M	$ -45.26M	$ -89.84M	$ -81.42M	$ -77.09M
EBITDA	$ -50.57M	$ -34.38M	$ -76.80M	$ -74.52M	$ -67.61M
Net Income	$ -54.19M	$ -31.81M	$ -88.61M	$ -88.35M	$ -76.68M
Balance Sheet
Cash & Short-Term Investments	$ 52.23M	$ 52.15M	$ 45.02M	$ 95.03M	$ 129.26M
Total Assets	$ 64.00M	$ 64.21M	$ 79.59M	$ 151.20M	$ 223.38M
Total Debt	$ 5.40M	$ 7.63M	$ 9.38M	$ 8.73M	$ 7.95M
Net Debt	$ -9.07M	$ -6.59M	$ -23.56M	$ -3.87M	$ -121.31M
Total Liabilities	$ 49.18M	$ 37.45M	$ 28.21M	$ 48.65M	$ 44.95M
Stockholders' Equity	$ 14.83M	$ 26.76M	$ 51.38M	$ 102.55M	$ 178.43M
Cash Flow
Free Cash Flow	$ -37.34M	$ -43.61M	$ -69.82M	$ -36.35M	$ -69.33M
Operating Cash Flow	$ -37.01M	$ -43.48M	$ -65.67M	$ -35.02M	$ -62.82M
Investing Cash Flow	$ 208.00K	$ -23.96M	$ 66.06M	$ -83.71M	$ 59.98M
Financing Cash Flow	$ 37.06M	$ 43.17M	$ 24.86M	$ 1.94M	$ 113.90M

Currency in USD

Abeona Therapeutics Earnings and Revenue History

Income Statement >

Abeona Therapeutics Debt to Assets

Balance Sheet >

Abeona Therapeutics Cash Flow

Cash Flow >

Abeona Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing